• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

商品代蛋鸭用鸭肝炎活疫苗免疫效力及母源抗体消长规律研究。

Live attenuated duck hepatitis virus vaccine in breeder ducks: Protective efficacy and kinetics of maternally derived antibodies.

机构信息

Department of Veterinary Infectious Diseases and Avian Diseases, College of Veterinary Medicine and Center for Poultry Diseases Control, Chonbuk National University, South Korea.

Department of Veterinary Infectious Diseases and Avian Diseases, College of Veterinary Medicine and Center for Poultry Diseases Control, Chonbuk National University, South Korea.

出版信息

Vet Microbiol. 2018 Jun;219:107-112. doi: 10.1016/j.vetmic.2018.04.021. Epub 2018 Apr 14.

DOI:10.1016/j.vetmic.2018.04.021
PMID:29778181
Abstract

Duck viral hepatitis type I is a rapidly spreading infection lethal in young ducklings, caused by the duck hepatitis A virus (DHAV). Vaccination of breeder ducks is a common practice to control DHAV. However, maintaining proper maternal antibody levels in large flocks is difficult. Therefore, a simple vaccination strategy that can induces stable high antibody levels through mass vaccination is desirable. We evaluated a DHAV vaccination strategy for breeder ducks involving oral administration under field conditions, and examined the kinetics of antibody response in the ducks and their progeny. The strategy included a primary intramuscular vaccination, followed by secondary and tertiary oral vaccinations. Five weeks after the primary vaccination, virus-neutralizing antibody titers increased by 8.4 ± 1.3 log. The titers remained stable at around 9.0 ± 1.1 log for up to 36 weeks. None of the progeny died when challenged with virulent DHAV at 1, 7 or 14 days of age. The transfer percentage of antibodies from the breeder ducks to their progeny was 12.8 ± 3.0%. When antibody levels of the progeny were measured from the day of hatching to 20 days of age, the levels steadily declined, reaching a mean titer of 0 log at 20 days. The half-life of the maternally derived antibodies against DHAV was 3.4 ± 1.1 days. Our vaccination strategy might be effective in breeder ducks because it can be easily applied and induced strong immunity. Moreover, our results might provide a foundation for the mechanistic study of maternally derived antibodies in passive protection.

摘要

鸭Ⅰ型病毒性肝炎是一种在雏鸭中迅速传播的致死性感染,由鸭肝炎 A 病毒(DHAV)引起。给种鸭接种疫苗是控制 DHAV 的常见做法。然而,在大型鸭群中维持适当的母源抗体水平是困难的。因此,需要一种简单的疫苗接种策略,可以通过大规模接种来诱导稳定的高抗体水平。我们评估了一种种鸭的 DHAV 疫苗接种策略,包括在野外条件下口服接种,并检查了鸭及其后代的抗体反应动力学。该策略包括肌肉内初次接种,然后进行二次和三次口服接种。初次接种后 5 周,病毒中和抗体滴度增加了 8.4±1.3 对数。在长达 36 周的时间里,抗体滴度稳定在 9.0±1.1 对数左右。当在 1、7 或 14 日龄时用强毒 DHAV 对其后代进行攻毒时,没有一只后代死亡。母源抗体从种鸭向其后代的传递率为 12.8±3.0%。当从孵化当天到 20 天测量后代的抗体水平时,抗体水平稳步下降,在 20 天时达到平均 0 对数滴度。DHAV 母源抗体的半衰期为 3.4±1.1 天。我们的疫苗接种策略可能对种鸭有效,因为它易于应用并能诱导强烈的免疫力。此外,我们的结果可能为母源抗体在被动保护中的机制研究提供基础。

相似文献

1
Live attenuated duck hepatitis virus vaccine in breeder ducks: Protective efficacy and kinetics of maternally derived antibodies.商品代蛋鸭用鸭肝炎活疫苗免疫效力及母源抗体消长规律研究。
Vet Microbiol. 2018 Jun;219:107-112. doi: 10.1016/j.vetmic.2018.04.021. Epub 2018 Apr 14.
2
Protective efficacy of a bivalent live attenuated vaccine against duck hepatitis A virus types 1 and 3 in ducklings.针对鸭肝炎 A 病毒 1 型和 3 型的二价活疫苗对雏鸭的保护效力。
Vet Microbiol. 2018 Feb;214:108-112. doi: 10.1016/j.vetmic.2017.12.018. Epub 2017 Dec 26.
3
[Development and evaluation of an inactivated bivalent vaccine against duck viral hepatitis].鸭病毒性肝炎二价灭活疫苗的研制与评价
Sheng Wu Gong Cheng Xue Bao. 2015 Nov;31(11):1579-88.
4
Molecular epidemiology of duck hepatitis a virus types 1 and 3 in China, 2010-2015.中国 2010-2015 年鸭甲型肝炎病毒 1 型和 3 型的分子流行病学研究。
Transbound Emerg Dis. 2018 Feb;65(1):10-15. doi: 10.1111/tbed.12741. Epub 2017 Oct 27.
5
Current status and future direction of duck hepatitis A virus vaccines.鸭甲肝病毒疫苗的现状与未来发展方向。
Avian Pathol. 2023 Apr;52(2):89-99. doi: 10.1080/03079457.2022.2162367. Epub 2023 Jan 19.
6
Development of duck hepatitis A virus type 3 vaccine and its use to protect ducklings against infections.鸭甲型肝炎病毒3型疫苗的研制及其用于保护雏鸭免受感染。
Vaccine. 2009 Nov 12;27(48):6688-94. doi: 10.1016/j.vaccine.2009.08.092. Epub 2009 Sep 9.
7
Protection of Ducklings from Duck Hepatitis A Virus Infection with ELPylated Duck Interferon-α.用 ELPylated 鸭干扰素-α保护雏鸭免受鸭肝炎 A 病毒感染。
Viruses. 2022 Mar 18;14(3):633. doi: 10.3390/v14030633.
8
Inactivated and live bivalent fowl adenovirus (FAdV8b + FAdV11) breeder vaccines provide broad-spectrum protection in chicks against inclusion body hepatitis (IBH).灭活和活的二价禽腺病毒(FAdV8b+FAdV11)种鸡疫苗为小鸡提供针对包涵体肝炎(IBH)的广谱保护。
Vaccine. 2018 Jan 29;36(5):744-750. doi: 10.1016/j.vaccine.2017.12.047. Epub 2017 Dec 29.
9
Development of the first officially licensed live attenuated duck hepatitis A virus type 3 vaccine strain HB80 in China and its protective efficacy against DHAV-3 infection in ducks.中国首个官方许可的减毒鸭甲型肝炎病毒 3 型活疫苗株 HB80 的研发及其对鸭 DHAV-3 感染的保护效力。
Poult Sci. 2024 Oct;103(10):104087. doi: 10.1016/j.psj.2024.104087. Epub 2024 Jul 11.
10
Vaccination of ducks with a whole-cell vaccine expressing duck hepatitis B virus core antigen elicits antiviral immune responses that enable rapid resolution of de novo infection.用表达鸭乙型肝炎病毒核心抗原的全细胞疫苗对鸭子进行接种可引发抗病毒免疫反应,从而能够迅速消除新出现的感染。
Virology. 2006 May 10;348(2):297-308. doi: 10.1016/j.virol.2005.12.032. Epub 2006 Feb 8.

引用本文的文献

1
Recombinant Bacillus subtilis Displaying DHAV-1 VP1 Protein as a Dual-Function Probiotic: Evaluation of Immunological Efficacy, Growth Performance, Antioxidant Capacity, and Intestinal Health in Cherry Valley Ducks.展示鸭甲型肝炎病毒1型VP1蛋白的重组枯草芽孢杆菌作为双功能益生菌:对樱桃谷鸭免疫功效、生长性能、抗氧化能力及肠道健康的评估
Probiotics Antimicrob Proteins. 2025 Aug 15. doi: 10.1007/s12602-025-10720-1.
2
Development of a blocking ELISA employing a VP1-specific monoclonal antibody for the detection of DHAV3 antibodies.利用VP1特异性单克隆抗体开发用于检测鸭甲型肝炎病毒3型抗体的阻断酶联免疫吸附测定法。
Poult Sci. 2025 Apr 5;104(6):105080. doi: 10.1016/j.psj.2025.105080.
3
The Impact of Genetic Variation on Duck Hepatitis A Virus (DHAV) Vaccine Efficacy: A Comparative Study of DHAV-1 and DHAV-3 Against Emerging Variant Strains.
基因变异对鸭甲型肝炎病毒(DHAV)疫苗效力的影响:DHAV-1和DHAV-3针对新兴变异株的比较研究
Vaccines (Basel). 2024 Dec 16;12(12):1416. doi: 10.3390/vaccines12121416.
4
Surface Display of Duck Hepatitis A Virus Type 1 VP1 Protein on Bacillus subtilis Spores Elicits Specific Systemic and Mucosal Immune Responses on Mice.1型鸭甲型肝炎病毒VP1蛋白在枯草芽孢杆菌芽孢表面的展示对小鼠引发特异性全身和黏膜免疫反应。
Probiotics Antimicrob Proteins. 2024 Jul 13. doi: 10.1007/s12602-024-10323-2.
5
Recombinant Duck Enteritis Virus-Vectored Bivalent Vaccine Effectively Protects Against Duck Hepatitis A Virus Infection in Ducks.重组鸭肠炎病毒载体二价疫苗有效预防鸭甲型肝炎病毒感染鸭
Front Microbiol. 2021 Dec 22;12:813010. doi: 10.3389/fmicb.2021.813010. eCollection 2021.